Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

Publisher: John Wiley & Sons Inc

E-ISSN: 2328-9503|2|5|534-547

ISSN: 2328-9503

Source: Annals Of Clinical And Translational Neurology, Vol.2, Iss.5, 2015-05, pp. : 534-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract